M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
Times Cited: 92
Times Cited: 92
Times Cited
Times Co-cited
Similarity
Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
43
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
39
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
35
Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
34
Interest in learning of personal genetic risk for cancer: a general population survey.
M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
31
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
29
Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
29
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
28
Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
27
Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
22
Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
19
Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
37
The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
18
Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
G Geller, T Doksum, B A Bernhardt, S A Metz. Cancer Epidemiol Biomarkers Prev 1999
G Geller, T Doksum, B A Bernhardt, S A Metz. Cancer Epidemiol Biomarkers Prev 1999
25
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
18
Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer.
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
34
Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
17
Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer.
I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
16
Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
19
Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
15
Genetic testing for cancer risk: a population survey on attitudes and intention.
Cornelia M Ulrich, Alan R Kristal, Emily White, Julie R Hunt, Sharon J Durfy, John D Potter. Community Genet 1998
Cornelia M Ulrich, Alan R Kristal, Emily White, Julie R Hunt, Sharon J Durfy, John D Potter. Community Genet 1998
28
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
15
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
14
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
14
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
13
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
13
Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
14
Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
13
Hereditary cancer risk notification and testing: how interested is the general population?
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
20
Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer.
B L Smith, M A Gadd, C Lawler, D J MacDonald, S C Grudberg, F S Chi, K Carlson, A Comegno, W W Souba. Surgery 1996
B L Smith, M A Gadd, C Lawler, D J MacDonald, S C Grudberg, F S Chi, K Carlson, A Comegno, W W Souba. Surgery 1996
16
BRCA1 and BRCA2: from molecular genetics to clinical medicine.
M A Blackwood, B L Weber. J Clin Oncol 1998
M A Blackwood, B L Weber. J Clin Oncol 1998
11
The prospect of predictive testing for personal risk: attitudes and decision making.
A L Wroe, P M Salkovskis, K A Rimes. Behav Res Ther 1998
A L Wroe, P M Salkovskis, K A Rimes. Behav Res Ther 1998
25
Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
12
Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
17
Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.
C Julian-Reynier, H Sobol, C Sévilla, C Noguès, P Bourret. Psychooncology 2000
C Julian-Reynier, H Sobol, C Sévilla, C Noguès, P Bourret. Psychooncology 2000
26
Attitudes toward colon cancer gene testing: factors predicting test uptake.
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
10
Comparison of the pattern of agenesis in the primary and permanent dentitions in a population characterized by agenesis in the primary dentition.
J Daugaard-Jensen, M Nodal, L T Skovgaard, I Kjaer. Int J Paediatr Dent 1997
J Daugaard-Jensen, M Nodal, L T Skovgaard, I Kjaer. Int J Paediatr Dent 1997
40
On the genetics of hypodontia and microdontia: synergism or allelism of major genes in a family with six affected members.
S P Lyngstadaas, H Nordbo, T Gedde-Dahl, P S Thrane. J Med Genet 1996
S P Lyngstadaas, H Nordbo, T Gedde-Dahl, P S Thrane. J Med Genet 1996
30
A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region.
N Galili, H S Baldwin, J Lund, R Reeves, W Gong, Z Wang, B A Roe, B S Emanuel, S Nayak, C Mickanin,[...]. Genome Res 1997
N Galili, H S Baldwin, J Lund, R Reeves, W Gong, Z Wang, B A Roe, B S Emanuel, S Nayak, C Mickanin,[...]. Genome Res 1997
13
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.
A K Ryan, J A Goodship, D I Wilson, N Philip, A Levy, H Seidel, S Schuffenhauer, H Oechsler, B Belohradsky, M Prieur,[...]. J Med Genet 1997
A K Ryan, J A Goodship, D I Wilson, N Philip, A Levy, H Seidel, S Schuffenhauer, H Oechsler, B Belohradsky, M Prieur,[...]. J Med Genet 1997
10
CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.
G Zhou, Y Chen, L Zhou, K Thirunavukkarasu, J Hecht, D Chitayat, B D Gelb, S Pirinen, S A Berry, C R Greenberg,[...]. Hum Mol Genet 1999
G Zhou, Y Chen, L Zhou, K Thirunavukkarasu, J Hecht, D Chitayat, B D Gelb, S Pirinen, S A Berry, C R Greenberg,[...]. Hum Mol Genet 1999
10
Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis.
A C Jones, J Austin, N Hansen, B Hoogendoorn, P J Oefner, J P Cheadle, M C O'Donovan. Clin Chem 1999
A C Jones, J Austin, N Hansen, B Hoogendoorn, P J Oefner, J P Cheadle, M C O'Donovan. Clin Chem 1999
10
Monozygotic twins with chromosome 22q11 deletion and discordant phenotype.
E Hatchwell. J Med Genet 1996
E Hatchwell. J Med Genet 1996
27
A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII).
M L Huie, A S Chen, S S Brooks, A Grix, R Hirschhorn. Hum Mol Genet 1994
M L Huie, A S Chen, S S Brooks, A Grix, R Hirschhorn. Hum Mol Genet 1994
11
Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss.
P M Kelley, D J Harris, B C Comer, J W Askew, T Fowler, S D Smith, W J Kimberling. Am J Hum Genet 1998
P M Kelley, D J Harris, B C Comer, J W Askew, T Fowler, S D Smith, W J Kimberling. Am J Hum Genet 1998
10
Congenital macular colobomas and short-limb skeletal dysplasia.
R D Smith, R M Fineman, D O Sillence, P D Lester, G W Nixon, D L Rimoin, R S Lachman. Am J Med Genet 1980
R D Smith, R M Fineman, D O Sillence, P D Lester, G W Nixon, D L Rimoin, R S Lachman. Am J Med Genet 1980
66
Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system.
A Kuklin, K Munson, D Gjerde, R Haefele, P Taylor. Genet Test 1997
A Kuklin, K Munson, D Gjerde, R Haefele, P Taylor. Genet Test 1997
10
Associated malformations and chromosomal defects in congenital diaphragmatic hernia.
R Bollmann, K Kalache, H Mau, R Chaoui, C Tennstedt. Fetal Diagn Ther 1995
R Bollmann, K Kalache, H Mau, R Chaoui, C Tennstedt. Fetal Diagn Ther 1995
12
Associated anomalies in individuals with polydactyly.
E E Castilla, R Lugarinho, M da Graça Dutra, L J Salgado. Am J Med Genet 1998
E E Castilla, R Lugarinho, M da Graça Dutra, L J Salgado. Am J Med Genet 1998
21
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.